Fortress Biotech (FBIO) Equity Ratio: 2013-2025
Historic Equity Ratio for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to 0.36.
- Fortress Biotech's Equity Ratio rose 458.50% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year increase of 458.50%. This contributed to the annual value of 0.16 for FY2024, which is 17.15% up from last year.
- According to the latest figures from Q3 2025, Fortress Biotech's Equity Ratio is 0.36, which was up 30.81% from 0.27 recorded in Q2 2025.
- Over the past 5 years, Fortress Biotech's Equity Ratio peaked at 0.62 during Q1 2021, and registered a low of -0.10 during Q3 2024.
- In the last 3 years, Fortress Biotech's Equity Ratio had a median value of 0.08 in 2023 and averaged 0.07.
- Per our database at Business Quant, Fortress Biotech's Equity Ratio plummeted by 131.82% in 2024 and then skyrocketed by 862.93% in 2025.
- Quarterly analysis of 5 years shows Fortress Biotech's Equity Ratio stood at 0.57 in 2021, then tumbled by 70.16% to 0.17 in 2022, then declined by 20.83% to 0.13 in 2023, then rose by 17.15% to 0.16 in 2024, then surged by 458.50% to 0.36 in 2025.
- Its Equity Ratio stands at 0.36 for Q3 2025, versus 0.27 for Q2 2025 and 0.18 for Q1 2025.